相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Population analysis of the pregnancy-related modifications in lopinavir pharmacokinetics and their possible consequences for dose adjustment
Marion Bouillon-Pichault et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Human Immunodeficiency Virus Diagnostic Testing of Infants at Clinical Sites in North America 2002-2006
Jennifer S. Read et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2009)
Lopinavir Exposure With an Increased Dose During Pregnancy
Mark Mirochnick et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2008)
Steady-state lopinavir levels in third trimester of pregnancy
Fiona Lyons et al.
AIDS (2007)
The tablet formulation of lopinavir/ritonavir provides similar bioavailability to the soft-gelatin capsule formulation with less pharmacokinetic variability and diminished food effect
Cheri Enders Klein et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2007)
Plasma lopinavir trough levels in a group of pregnant women on lopinavir, ritonavir, zidovudine, and lamivudine
Kaveh Manavi et al.
AIDS (2007)
Virological and pharmacological parameters predicting the response to lopinavir-ritonavir in heavily protease inhibitor-experienced patients
AG Marcelin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A activity) during pregnancy
TS Tracy et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2005)
Quality assurance program for clinical measurement of antiretrovirals: AIDS Clinical Trials Group proficiency testing program for pediatric and adult pharmacology laboratories
DT Holland et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Virological, intracellular and plasma pharmacological parameters predicting response to lopinavir/ritonavir (KALEPHAR Study)
D Breilh et al.
AIDS (2004)
Pharmacokinetics of antiretrovirals in pregnant women
M Mirochnick et al.
CLINICAL PHARMACOKINETICS (2004)
Human immunodeficiency virus type 1 genotypic and pharmacokinetic, determinants of the virological response to lopinavir-ritonavir-containing therapy in protease inhibitor-experienced patients
B Masquelier et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
ABT-378/ritonavir plus stavudine and lamivudine for the treatment of antiretroviral-naive adults with HIV-1 infection: 48-week results
RL Murphy et al.
AIDS (2001)
分享论文
